Homologues of the SHARPIN (SHANK-associated RH domain-interacting protein) gene have been identified in the human, rat and mouse genomes. SHARPIN and its homologues are expressed in many tissues. SHARPIN protein forms homodimers and associates with SHANK in the post-synaptic density of excitatory neurotransmitters in the brain. SHARPIN is hypothesized to have roles in the crosslinking of SHANK proteins and in enteric nervous system function. We demonstrate that two independently arising spontaneous mutations in the mouse Sharpin gene, cpdm and cpdm Dem , cause a chronic proliferative dermatitis phenotype, which is characterized histologically by severe inflammation, eosinophilic dermatitis and defects in secondary lymphoid organ development. These are the first examples of disease-causing mutations in the Sharpin gene and demonstrate the importance of SHARPIN protein in normal immune development and control of inflammation.
Introduction
The chronic proliferative dermatitis mutation (cpdm) was first observed as a spontaneous genetic disease in C57BL/KaLawRij mice at the TNO Institute, Rijswijk, The Netherlands. Mutant mice have a shortened lifespan, runted appearance and a characteristic progressive dermatitis with alopecia that first becomes clinically apparent at 3-4 weeks of age. Males and females are affected equally. The mutant phenotype includes multiorgan inflammation with eosinophilia, defective T H 1 cytokine production, splenomegaly and dermatitis with granulocytic infiltrates, ortho-and parakeratotic hyperplasia, and follicular dystrophy. 1, 2 Peyer's patches are absent in adult mice, and remaining secondary lymphoid organs lack B-cell follicles, follicular dendritic cells and germinal centers. The B-and T-cell areas of the spleen are poorly defined, and the marginal zone is absent. B-cell isotype switching and immunoglobulin production is also affected, with significantly diminished serum immunoglobulins (Ig) IgG, IgA and IgE. 3 
Results
We initially localized the cpdm gene to an approximately 1.2 cM interval on mouse Chromosome 15 (m.Chr.15) between markers D15Mit156 and D15Mit2 using an intraspecific cross of C57BL/KaLawRij-cpdm/cpdm with BALB/cJ. An intersubspecific cross using CAST/EiJ was created to increase polymorphisms in this region for high-resolution mapping; however, the skin phenotype in some mice was highly variable, likely due to the contribution of CAST modifier genes. 4 To avoid these complications, we developed a congenic strain, C.CAST-(D15Mit156-D15Mit2)/Sun, moving the CAST critical interval for cpdm onto the BALB/cJ background to advance fine mapping. This congenic strain retained a high rate of polymorphism in the m.Chr.15 interval of interest compared to C57BL/KaLawRij-cpdm/cpdm but lacked the purported unlinked CAST-derived modifier genes altering the cpdm phenotype. Using the original (CAST/EiJ þ / þ Â C57BL/KaLawRij-cpdm/cpdm) F2 intercross and over 1100 mice from the new C.CAST-(D15Mit156-D15Mit2)/Sun Â C57BL/KaLawRij-cpdm/cpdm F2 intercross, seven critical recombinants were identified, and the cpdm genetic interval was narrowed to o0.2 cM (372 kb). The cpdm interval contained 21 identified genes according to the Ensembl (http://www.ensembl.org/ index.html) mouse genome database annotation (Supplementary Table 1 ). The interval is located in a region of conserved synteny with human Chromosome 8q24.3 (h.Chr.8q24.3); comparison of the mouse and human genomic sequences demonstrates a complete conservation of gene order and gene content between the two species.
An independent spontaneous mutation resulting in a similar phenotype was identified in OcB-3/Dem recombinant congenic mice at The Netherlands Cancer Institute, Amsterdam.
Allelism of this second mutation with cpdm was confirmed by heterozygous matings (C57BL/KaLawRij þ / cpdm Â Ocb-3/Dem þ /cpdm) that produced affected F1 offspring at expected Mendelian ratios. This second strain was given the gene symbol cpdm Dem , 4 and backcrossed onto the BALB/cByJ inbred strain for 10 generations for colony maintenance purposes, creating the CBy.OcB3 congenic strain.
Genes in the critical region for cpdm were initially screened by real-time quantitative PCR (QPCR) assay, which suggested Sharpin as a strong candidate, the only gene in the interval that was significantly downregulated in testes or spleen of both C57BL/KaLawRij-cpdm/cpdm and CBy.OcB3-cpdm Dem /cpdm Dem mice as compared to the same tissues in their respective controls (data not shown). We began to examine genes in the interval by direct sequence analysis of cDNA, using sequence obtained from NCBI m34 via Ensembl for comparison. Slc39a4, Gpaa1, Hsf1 and Sharpin were completed, and independent mutations were identified in exon 1 of Sharpin for each of the two cpdm alleles. Examination of the complete genomic sequence of Sharpin revealed that these changes were not found in control mice of the parent strains nor in C57BL/10J or BALB/cByJ strains. In the C57BL/KaLawRij-cpdm/cpdm mice, a single base pair deletion was observed at the 3 0 -end of exon 1 (Figure 1 ), resulting in a shift of the open reading frame predicted to cause an early stop codon beginning at position 624 (numbered sequence is based on Ensembl cDNA transcript ENSMUST00000023211). The CBy.OcB3-cpdm Dem /cpdm Dem mouse showed a C to A transition at position 434 near the 5 0 -end of Exon 1, followed by a 14-bp deletion of nucleotides 438-451 ( Figure 2 ). The transition does not result in an amino acid change, but the 14-bp deletion disrupts the reading frame and results in an early stop codon beginning at position 552. To ensure that this change represented a mutation from the strain of origin, we obtained and sequenced genomic DNA from wild-type Ocb3/Dem mice (kind gift of Dr M Lipoldova, Institute of Molecular Genetics, Academy of Sciences, Czech Republic), and determined that these changes are not seen in the wild-type allele (Figure 2 Figure 3 ). The size is consistent with the predicted 39.9 kDa protein sequence for the mouse, and slightly smaller than the 45-kDa major band demonstrated by Lim et al. (2001) in rat tissues, probably reflecting species differences. Minor bands (o37 and 440 kDa) similar to those described for the rat were also observed in adult wild-type mice (data not shown). The larger bands appear to be non-specific, as they were visible in adult cpdm/cpdm mice and controls, though barely detectable in mice o2 weeks of age. The smaller bands were not found in young mutant mice, and barely . Sharpin is located in a gene-rich region on m.Chr.15 and the BAC carries other additional genes: 5-oxoprolinase (Oplah), exosome component 4 (Exosc4), cytochrome c-1 (Cyc1), GPI anchor attachment protein 1 (Gpaa1), brain protein16 (Brp16), MAF1 homolog (S. cerevisiae) (Maf1), scleraxis (Scx), testis-specific serine kinase 5 (Tssk5) and D330001F17Rik, with unknown function. Ensembl further predicts two novel genes in the chromosomal region found on the BAC. None of these genes has been associated previously with normal immune function. Since the C57BL/KaLawRij sequence is nearly identical to B6 in this region, and the cpdm mutation is purely recessive, a B6 transgenic founder line would present difficulties in genotyping an F2 mutant mouse rescued by the B6 transgene vs a heterozygous mouse bearing the transgene. The FVB/NJ strain was chosen to allow for selection of polymorphic markers for genotyping, for large average litter production, relative ease in obtaining many synchronous embryos and larger egg pronuclei, simplifying microinjection.
Spontaneous mutations in the mouse
BAC-positive founder animals were identified by PCR using a primer set designed to amplify a B6/FVB polymorphic region located on the BAC close to Sharpin, in addition to primers specific for the bacterial region of the BAC. None of the BAC-bearing transgenic mice demonstrated gross abnormalities, and both males and females were fertile. Three FVB transgenic lines were established and subsequently crossed with mice bearing the C57BL/KaLawRij-cpdm allele to determine whether the transgene could 'rescue' (prevent onset of) the dermatitis and other immunologic defects. Any F2 offspring of these crosses bearing two mutant Sharpin alleles and also carrying the transgene were expected to have a wild-type phenotype.
Ten mice bearing two Sharpin mutant alleles and positive for the BAC were examined, and all of them were grossly and histologically free of the disease phenotype at 12 weeks of age. These included mice from each of the three founder lines. Another 10 mice bearing two Sharpin mutant alleles but negative for the BAC developed the cpdm phenotype (Figure 4 ). The cpdm phenotype was completely penetrant on the mixed F2 genetic background in absence of the transgene. Not surprisingly from our experience with the early mapping crosses, we observed an influence of the FVB background on the severity of the disease phenotype, resulting in milder skin disease with delayed age of onset, and potentially extended lifespan in some mice. One mouse had two small submucosal aggregates of lymphoid tissue in the distal small intestine, but no organized follicular structures were present (Figure 4e ). We are presently aging cohorts of mice from this colony and developing a backcross of the BAC onto the C57BL/KaLawRij-cpdm/cpdm background to determine long-term effects of the mixed genetic background.
Discussion
SHARPIN and its homologues are expressed in multiple tissues in humans and mice (GNF SymAtlas, v.1.1.1, http://www.wombat.gnf.org/SymAtlas/). Orthologues are also found in rats, dogs, chimpanzees (Mouse Genome Informatics, http://www.informatics.jax.org/), and probably other species (Ensembl, http://www. ensembl.org/). SHARPIN is enriched in the post-synaptic density of excitatory synapses in the rat brain, where it may interact with SHANK protein.
5 SHARPIN was also hypothesized to play a role in enteric motor transmission in humans and mice. 6 Here we report two independently occurring, spontaneous mutations in the mouse Sharpin gene, cpdm and cpdm Dem . Cpdm/cpdm mice demonstrate defective secondary lymphoid organ development, multiorgan inflammation with a T H 2 dominated cytokine milieu, dermatitis, decreased fertility and shortened lifespan. We have not observed neurological defects in cpdm/cpdm mice; however, the skin phenotype becomes obvious at 3-5 weeks of age and its rapid progression may preclude any casual observation of subtle behavioral changes, particularly of symptoms associated with learning or memory deficits. Affected mice over 12 weeks of age were not examined.
The function of SHARPIN is unknown; however, Lim et al. (2001) reported that the N terminus bears a coiledcoil domain that may be associated with dimerization or DNA binding functions. The C terminus shares homology with the protein kinase C binding protein, RBCK1; in RBCK1, this region is associated with DNA binding and transcriptional activity. 5 SHARPIN also contains a Cterminal zinc-finger domain highly similar to that of a Ran-binding protein. In Ran-BP, this domain binds to Ran-GDP, and is associated with nuclear transport. This region is conserved between rat and mouse, and one transcript of the human gene. 6 The mouse mutations discussed here both result in early truncation; the cpdm mutation causes truncation immediately following the coiled-coil domain, and in cpdm Dem all of these predicted domains are lost ( Figure 5 ).
These are the first known examples of disease-causing mutations in Sharpin and provide valuable new information for the study of secondary lymphoid organ development and control of inflammatory processes. The lack of cellular organization in these tissues is likely to be a contributing factor in the defective humoral response of cpdm/cpdm mice, since intimate communication between B cells, T cells, and antigen-presenting cells is critical for this function. Sharpin is highly expressed in B and T cells; however, transplantation of mutant bone marrow into adult or neonatal wild-type mice does not confer the disease phenotype, 1 suggesting a stromal component as well.
We have confirmed two independent mutations of the mouse Sharpin gene in cpdm and cpdm Dem mutant mice, demonstrated the loss of SHARPIN protein expression in these mutant mice, and established transgenic rescue of the disease phenotype by BAC microinjection. We are presently working to create time-and tissue-specific targeted mutations of SHARPIN in mice to determine the specific role of the protein in affected tissues.
There are currently no reports of orthologous human diseases mapping to the h.Chr 8q24.3 region, and no disease known to be associated with mutations in human SHARPIN. Future plans include screening of human patients with immunodeficiency syndromes and chronic eosinophilic inflammation for mutations in the SHARPIN gene.
Materials and methods

Mice
Colonies of C57BL/KaLawRij-cpdm/cpdm and wildtype mice were maintained at The Jackson Laboratory under conventional specific pathogen-free (SPF) conditions. Female cpdm/cpdm mice are infertile, 7 and mutant colonies were maintained by mating homozygous male Â heterozygous female, or heterozygote Â heterozygote. Normal littermate controls were wild type as determined by test matings or sequencing of DNA, or heterozygotes, as indicated.
The original OcB-3/Dem mutation occurred at the Institute of Molecular Genetics, Academy of Sciences, Czech Republic. CBy.OcB3-cpdm Dem /cpdm Dem and their BALB/cByJ controls were maintained at The Jackson Laboratory under conventional SPF conditions. Both male and female homozygotes of the CBy.OcB3 strain are infertile (data not shown) and the colony was maintained by heterozygous matings determined by genotype.
BAC microinjection and rescue
The BAC was purchased from BACPAC resources (Oakland, CA, USA) and prepared using a Qiagen The skin of wild type and BAC rescued cpdm/cpdm mutant mice (left columns) has a thin epidermis with no evidence of dermal inflammation. By contrast, the epidermis of BAC-negative cpdm/cpdm mutant mice (right columns) is typically hyperplastic with marked dermal inflammation, hyperkeratosis and numerous apoptotic keratinocytes. Background modifier genes from the FVB strain are likely responsible for the mild mutant phenotype occasionally observed in BAC-negative F2 mutant mice (far right). This effect is most evident in the skin, however mild inflammation is present histologically and scattered apoptotic keratinocytes are seen. (b) Organized Peyer's patches are found in the antimesenteric wall of the small intestine in wild type and BAC-rescued cpdm/cpdm mice, but absent in BAC-negative cpdm/cpdm mice. (c) Cortical B cell follicles are seen in the lymphocyte-rich lymph nodes of wild type and BAC rescued cpdm/cpdm mice. These structures are effaced in BAC-negative cpdm/cpdm mice; reticuloendothelial cell hyperplasia and inflammatory cells are common. (d) The splenic white pulp is well defined in wild type and BAC rescued cpdm/cpdm mice. BAC-negative cpdm/cpdm mice lack this normal architecture. (e) Small aggregates of lymphoid tissue were observed in submucosa of the ileum of one BAC-negative F2 'mild' cpdm/cpdm mutant mouse; however, no organized lymphoid tissues (that is, Peyer's patches) were found.
Large-Construct Kit (Valencia, CA, USA) according to the manufacturer's instructions. The presence of Sharpin in the BAC was confirmed before and after kit purification by PCR, using primers previously designed for sequencing the gene. Sequencing gel-purified PCR products following BAC purification verified that Sharpin was present in the final product. Microinjection of the BAC was accomplished through the TJL Cell Biology and Microinjection Service. This resulted in 434 FVB/NJ embryos implanted into 20 recipient females, yielding 37 pups, which were weaned and delivered to our colony. Founder mice were identified by PCR using primer sets specific for the vector (left primer -GGTCGTTTGACTG GACGATT; right primer -GCCCTTAACCCTGTGAC AAA) and a marker polymorphic between the B6 (125 BP) and FVB (approximately 140 bp) strains, located close to Sharpin on the BAC (left primer: 5 0 -CAGCTTTT TAAACTGTGGGTCA-3 0 ; right primer: 5 0 -AGCGTAG TATGTGTGTGCAAA-3 0 ). To establish rapidly a colony while following segregation of the cpdm allele by genotype, heterozygous mice from the C.CAST-(D15Mit156-D15Mit2)/Sun Â C57BL/KaLawRij-cpdm/cpdm mapping cross were bred to FVB/NJ BAC þ mice. Some FVB/NJ BAC þ females were also bred to C57BL/ KaLawRij-cpdm/cpdm males. F1 offspring genotyped at these loci as FVB/cpdm BAC þ were crossed with FVB/ cpdm BACÀ mice, and F2 offspring were identified as FVB/FVB BACÀ, cpdm/cpdm BACÀ, cpdm/cpdm BAC þ (rescue) or heterozygous (normal) mice with and without the BAC.
Quantitative real-time PCR Sequences for candidate genes were exported from Ensembl and copied into Primer3 software v0.1. beta 1a (The Whitehead Institute for Biomedical Research). Primers were designed in accordance with universal thermocycling requirements for reverse transcriptase-PCR using the ABI 7900HT. Primer sequences were BLASTed using the UCSC Genome Browser (http:// www.genome.ucsc.edu/) to validate their specificity, and tested by PCR using control mouse genomic and cDNA. RNA was extracted from the spleen and testes of 3 C57BL/KaLawRij-cpdm/cpdm, 3 C57BL/KaLawRij þ / þ , 3 CBy.OcB3-cpdm Dem /cpdm Dem and 3 CBy.OcB3 þ / þ adult male mice, aged 9-11 weeks. Briefly, spleen and testis samples were stored in RNAlater (Ambion, Austin, TX, USA) as per the manufacturer's instructions and homogenized in TRIzol (Invitrogen, Carlsbad, CA, USA). Total RNA was isolated by standard TRIzol methods, and quality was assessed using an Agilent 2100 Bioanalyzer instrument and RNA 6000 Nano LabChip assay. Total RNA was then treated with RNase-free DNase I (Qiagen) according to the manufacturer's protocol.1 mg of total RNA was then reverse transcribed with random decamers and M-MLV RT using the Message Sensor RT Kit (Ambion).
Each reaction consisted of 5 ml of 2 Â SYBR green master mix (ABI, Foster City, CA, USA), 3.0 ml dH2O, 1.5 ml of 0.5 mm forward and reverse primers and 0.5 ml of diluted (1:10) cDNA. ABI 384-well plates with optical adhesive covers (ABI) were used for three technical replicates each of three mutants and three controls from each cpdm strain. Quantitative real-time PCR assay was run on the ABI Prism 7900HT Signal Detection System v2.0 using default conditions. Global pattern recognition software was used to compare the change of expression of each gene in the interval normalized to every other gene in the array. In this way, genes with significant expression changes were readily identified from healthy baseline profiles. 8, 9 Genomic sequence analysis Genomic DNA was obtained from tail tips in accordance with ACUC approved protocols. DNA was extracted using a Dneasy Tissue Kit (Qiagen) in accordance with the manufacturer's instructions. Genomic sequence of candidate genes was exported from Ensembl and overlapping primer pairs were designed to cover the entire sequence, using the Primer Express v2.0 (ABI) or Primer3 software programs. DNA was amplified by PCR and gelpurified using a QIAquick Gel Extraction Kit (Qiagen). Purified DNA products were submitted with 6.6 pmol of appropriate primer to the DNA Sequencing Service at The Jackson Laboratory and analyzed by Big Dye Terminator Cycle Sequencing Chemistry on an ABI 3700. The resulting sequences were evaluated for potential mutations using Sequencher v4.1.4 software (Gene Codes Corp., Ann Arbor, MI, USA).
Western blotting
Rabbit antisera containing primary antibody to SHARPIN was the kind gift of Dr Eunjoon Kim (Korea Advanced Institute of Science and Technology, yuseong-gu, Daejeon, Korea). The anti-sharpin rabbit serum was purified using a 1 ml HiTrap protein G column from Amersham Biosciences (Piscataway, NJ, USA). The serum was diluted 1:1 with 20 mM sodium phosphate, 150 mM NaCl pH 7.0 and centrifuged for Spontaneous mutations in the mouse Sharpin gene RE Seymour et al 10 min at 10 K g before filtering the supernatant through a Gelman Sciences LC13 0.45 mm syringe filter. The serum was loaded onto the column using a peristatic pump at 0.4 ml/min and washed with the phosphate buffer at 0.7 ml/min until zero absorbance at 280 nm. The column was then reversed and eluted with 0.1 M glycine (pH 2.5) collecting 0.5 ml fractions. Fractions were immediately neutralized with 20% volume of 1 M Tris (pH 8.3). The 280 nm absorbing fractions were pooled and dialyzed against phosphate-buffered saline with 0.02% azide. Cell lysates were obtained by homogenizing spleen tissue of p2-week old, age and sex-matched mutant and control mice of each strain in Tris/NaCl western blot lysis buffer with IGEPAL CA-630 lysis detergent and a protease inhibitor cocktail (Roche, Indianapolis, IN, USA). Proteins were quantitated using a Bio-Rad DC Protein detection assay (Bio-Rad, Hercules, CA, USA) and read by Spectramax 250 (Molecular Devices, Sunnyvale, CA, USA). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel electrophoresis and membrane transfer were carried out by standard methods using 12% PAGE Gold Precast gels (Cambrex BioScience, Rockland, ME, USA) and nitrocellulose membranes (Immobilon-P, Millipore, Bedford, MA, USA). Membranes were blocked with 5% dry milk in Tris-buffered saline Tween (TBST). Anti-SHARPIN antibody (1.84 mg/ml) was used at 1:500 in TBST.
The secondary antibody was horseradish-peroxidase conjugated donkey anti-rabbit IgG (Research Diagnostics, Inc., Flanders, NJ, USA) at 1:25 000 dilution in TBST. Membranes were developed using electrochemiluminescence þ Western Blot Detections System (Amersham Biosciences).
As a loading control, antibodies were stripped from the membranes using a 100 mM 2-ME, 2% sodium dodecyl sulfate, 62.5 mM solution at 501C for 30 minutes and reblotted as described above, using mouse IgG1 anti-b actin antibody at a 1:5000 dilution (clone AC-15; Sigma, St Louis, MO, USA) and HRP-conjugated goat anti-mouse secondary at 1:10 000 (A-0412; Sigma). Western blot gel analysis was performed using Image J 1.34 s software (http://www.rsb. info.nih.gov/ij/).
